EPHA4 and amyotrophic lateral sclerosis: Recently, several reports have implicated EphA4 as a disease modifier in amyotrophic lateral sclerosis (ALS)6–8 and indicated that either genetic or pharmacological inhibitors of EphA4 would reduce disease progression of ALS; however, the potential mechanism underlying this novel effect of EphA4 is still unclear.